Atea Pharmaceuticals Inc (AVIR)

Cash & Short-Term Investments

$219.47M

Quarterly · Period ending: · USD

AVIR logo

AVIR Cash & Short-Term Investments

Latest reported$219.47M
AVIR Quarterly Cash & Short-Term Investments ($21.66M → $219.47M)
High-resolution chart · PNG

AVIR cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
219,465,000
256,006,000
301,830,000
329,309,000
379,713,000
425,436,000
454,721,000
482,813,000
502,214,000
541,491,000
578,106,000
595,126,000
608,062,000
620,488,000
646,709,000
664,975,000
684,480,000
705,545,000
764,375,000
839,660,000
816,460,000
833,751,000
850,117,000
105,383,000
115,792,000
17,147,000
21,661,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.